IDXX up +0.61% percent right now. $IDXX High is at
Post# of 85178
Recent News posted below.
IDXX Idexx Laboratories Recent Headline News
Idexx Laboratories Earnings Hindsight: Up 7.4% in Last 17 Days (IDXX)
Comtex SmarTrend(R) - 43 mins ago
17 days ago, on October 24th, 2014, Idexx Laboratories (NASDAQ:IDXX) reported its earnings. Analysts, on average, expected earnings of $0.86 per share on sales of $371.3 million. Idexx Laboratories actually reported earnings of $1.05 per share on sales of $383.5 million, beating EPS estimates by $0.19 and beating revenue estimates by $12.2 million. Since the company's report, shares of Idexx Laboratories have risen from $135.20 to $145.16, representing a gain of 7.4% in the past 17 days.
IDXX: 147.25 (+2.09)
Idexx Laboratories Has Returned 17.5% Since SmarTrend Recommendation (IDXX)
Comtex SmarTrend(R) - Wed Nov 05, 9:25AM CST
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on October 21st, 2014 at $122.52. In approximately 2 weeks, Idexx Laboratories has returned 17.52% as of today's recent price of $143.98.
IDXX: 147.25 (+2.09)
Comparing America's 3 Largest Diagnostic Substances Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 03, 12:03PM CST
QDEL: 27.92 (+0.05), NEOG: 43.98 (+0.97), IDXX: 147.25 (+2.09)
Quarterly Earnings Releases and Recognitions - Research Reports on GlaxoSmithKline, IDEXX, BioMarin, GE and Lockheed Martin
PR Newswire - Wed Oct 29, 8:30AM CDT
Today, Analysts Review released its research reports regarding GlaxoSmithKline plc (NYSE: GSK), IDEXX Laboratories, Inc. (NASDAQ: IDXX), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), General Electric Company (NYSE: GE) and Lockheed Martin Corporation (NYSE: LMT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7542-100free.
LMT: 187.15 (+1.00), GE: 26.44 (+0.03), BMRN: 87.36 (+3.45), IDXX: 147.25 (+2.09), GSK: 45.17 (+0.26), NVS: 92.57 (+0.81)
IDEXX Laboratories (IDXX) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 7:57AM CDT
IDEXX Laboratories (IDXX) Shares March Higher, Can It Continue?
IDXX: 147.25 (+2.09)
IDEXX Tops Q3 Earnings and Revenues; Guidance Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:10PM CDT
Since the news release, IDEXX's (IDXX) share price has climbed 9.8% to eventually close at $138.76 yesterday.
ATEC: 1.43 (+0.04), EW: 124.38 (+1.62), IDXX: 147.25 (+2.09), ANGO: 16.99 (+0.04)
Today's Strong And Under The Radar Stock Is Idexx Laboratories (IDXX)
at The Street - Tue Oct 28, 8:51AM CDT
Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a strong and under the radar candidate
IDXX: 147.25 (+2.09)
IDEXX Laboratories, Inc. Is as Fit as a Butcher's Dog
Brian Orelli, The Motley Fool - Motley Fool - Fri Oct 24, 6:56PM CDT
Shares of IDEXX Laboratories jumped 7% today after reporting a solid third quarter, raising 2014 guidance, and issuing 2015 guidance that looks even better. The stock of the animal health-test provider soared to a 52-week and all-time high. ...
IDXX: 147.25 (+2.09)
Idexx Laboratories Set to Possibly Pullback After Yesterday's Rally of 7.00%
Comtex SmarTrend(R) - Fri Oct 24, 4:12PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $130.06 to a high of $140.42. Yesterday, the shares gained 7.0%, which took the trading range above the 3-day high of $126.42 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 147.25 (+2.09)
IDEXX Laboratories' (IDXX) CEO Jon Ayers on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 24, 1:02PM CDT
IDXX: 147.25 (+2.09)
Idexx Q3 income up 14%
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 10:00AM CDT
IDXX: 147.25 (+2.09)
Idexx beats Street 3Q forecasts
Automated Insights - Fri Oct 24, 6:27AM CDT
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported net income of $52.1 million in its third quarter.
IDXX: 147.25 (+2.09)
IDEXX Laboratories beats by $0.15, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 6:07AM CDT
IDXX: 147.25 (+2.09)
IDEXX Laboratories Announces Third Quarter Results
PR Newswire - Fri Oct 24, 6:00AM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported that revenues for the third quarter of 2014 increased 13% versus the prior year period to $384 million. Organic revenue growth1 for the third quarter of 2014 versus the prior year period was also 13%, or 11% normalized for changes in distributor inventory2. Earnings per diluted share ("EPS" for the quarter ended September 30, 2014 increased 21% from the prior year period to $1.03. Adjusted EPS3 for the quarter was $1.05.
IDXX: 147.25 (+2.09)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 4:30PM CDT
WYN: 77.64 (+0.32), SFE: 20.00 (+0.22), F: 13.98 (-0.19), OCR: 68.83 (+0.86), B: 36.53 (+0.11), SXC: 23.26 (-0.41), VTR: 68.58 (+0.32), UPS: 109.05 (+0.72), DLPH: 69.96 (+0.37), CHH: 53.03 (+0.32), LYB: 87.91 (+0.45), COG: 33.19 (-0.43), SHPG: 200.86 (+2.28), TCB: 15.69 (+0.31), AVY: 48.03 (+0.29), AAN: 26.04 (+0.34), MGLN: 60.03 (+0.38), STT: 78.00 (+0.19), FNFG: 7.46 (+0.02), IMGN: 9.94 (+0.17), EDU: 21.60 (-0.75), BMY: 58.60 (+0.28), DTE: 83.69 (+0.38), LEA: 93.17 (+0.82), MCO: 99.58 (+0.63), FLIR: 33.22 (-0.56), IMS: 24.40 (-0.06), LPNT: 65.88 (+0.36), ERIC: 11.62 (-0.18), PG: 89.39 (+0.26), IDXX: 147.25 (+2.09), WBC: 101.78 (-0.20), NDAQ: 43.93 (+0.05), CL: 68.45 (+0.40)
Oracle Enterprise Manager Enables Seamless IT Management and Visibility for IDEXX Laboratories
Marketwired - Wed Oct 15, 7:04AM CDT
Oracle (NYSE: ORCL)
IDXX: 147.25 (+2.09), ORCL: 40.42 (+0.48)
IDEXX Laboratories to Release 2014 Third Quarter Financial Results
PR Newswire - Tue Oct 14, 12:45PM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2014 third quarter financial results for Friday, October 24, 2014 at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
IDXX: 147.25 (+2.09)
IDEXX Laboratories Poised on Strong CAG Growth Globally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 5:40PM CDT
On Oct 7, 2014, we updated our research report on IDEXX Laboratories, Inc. (IDXX).
HNSN: 0.77 (-0.06), EW: 124.38 (+1.62), IDXX: 147.25 (+2.09), HOLX: 26.52 (+0.31)
Idexx Laboratories (IDXX) Marked As A Barbarian At The Gate
at The Street - Wed Oct 01, 2:02PM CDT
Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
IDXX: 147.25 (+2.09)
IDEXX Announces Several Milestones in its US All-Direct CAG Distribution Strategy
PR Newswire - Wed Oct 01, 9:29AM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported that it had selected United Parcel Service (UPS) to provide third party logistic services in support of its strategy to go all-direct with US companion animal veterinary practices. This agreement builds on IDEXX's distribution and logistics capability, and provides for five warehouse and shipping locations strategically located across the US, three of which are provided by UPS' third party logistics services.
IDXX: 147.25 (+2.09)